FGF2 and neoplasm: To confirm the results from immuonofluorescence and flow cytometry indicating that the number of fibrocyte-like cells was increased and that these were the FGF2-producing cells in the bevacizumab-resistant tumours, we isolated and characterized the fibrocyte-like cells from mouse tumour tissue.